NCT03351933View on ClinicalTrials.gov

Anti-Hepatitis A Virus, Pharmacokinetics, and Safety of Immune Globulin (Human)

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 31, 2017

Primary Completion Date

April 27, 2018

Study Completion Date

July 19, 2018

Conditions
Anti-Hepatitis A Antibody Levels in Heathy Subjects
Interventions
BIOLOGICAL

Immune Globulin (Human)

A single 0.2 mL/kg IM injection of Immune Globulin (Human) (GamaSTAN) was administered in healthy subjects.

Trial Locations (1)

66212

Vince & Associates Clinical Research, Inc., Overland Park

Sponsors
All Listed Sponsors
lead

Grifols Therapeutics LLC

INDUSTRY